Elexacaftor-tezacaftor-ivacaftor in patients with cystic fibrosis ineligible for clinical trials: a 24-week observational study

by Libor Fila, Alzbeta Grandcourtova, Alena Bilkova, Pavel Drevinek
Published 2023-06-01

What matters in chronic Burkholderia cenocepacia infection in cystic fibrosis: Insights from comparative genomics.

by Jaroslav Nunvar, Vaclav Capek, Karel Fiser, Libor Fila, Pavel Drevinek
Published 2017-12-01

The long-term effect of elexacaftor/tezacaftor/ivacaftor on cardiorespiratory fitness in adolescent patients with cystic fibrosis: a pilot observational study

by Nela Stastna, Lenka Hrabovska, Pavel Homolka, Lukas Homola, Michal Svoboda, Kristian Brat, Libor Fila
Published 2024-05-01

Biopsy of lung lesions under CT control

by Miloslav Marel, Radek Padr, Libor Fila, Dmitry Rakita, Fernando Casas Mendez, Linda Capkova, Vaclav Capek, Radim Pavlik
Published 2021-11-01

Ivacaftor in cystic fibrosis adults: Czech experience with six years of follow-up

by Libor Fila, Lucie Valentova Bartakova, Alzbeta Grandcourtova, Miloslav Marel, Radovan Drnek, Alena Bilkova, Milan Macek, Pavel Drevinek
Published 2016-06-01

Lung cancer, pulmonary emphysema and pleural effusion: An autopsy study

by Miloslav Marel, Leona Koubkova, Zuzana Kovarikova, Alzbeta Grandcourtova, Frantisek Petrik, Hana Hroudova, Linda Capkova, Roman Kodet, Libor Fila
Published 2015-12-01